(Q34562177)

3 August 2017

Mesenchymal stem cell as salvage treatment for refractory chronic GVHD (English)

1 reference

3 August 2017

mesenchymal stem cell

1 reference

J Y Weng

1

1 reference

3 August 2017

X Du

2

1 reference

3 August 2017

S X Geng

3

1 reference

3 August 2017

Y W Peng

4

1 reference

3 August 2017

Z Wang

5

1 reference

3 August 2017

Z S Lu

6

1 reference

3 August 2017

S J Wu

7

1 reference

3 August 2017

C W Luo

8

1 reference

3 August 2017

R Guo

9

1 reference

3 August 2017

W Ling

10

1 reference

3 August 2017

C X Deng

11

1 reference

3 August 2017

P J Liao

12

1 reference

3 August 2017

A P Xiang

13

1 reference

3 August 2017

language of work or name

English

0 references

publication date

6 September 2010

1 reference

Bone Marrow Transplantation

3 August 2017

1 reference

3 August 2017

45

1 reference

3 August 2017

12

1 reference

3 August 2017

1732-1740

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2010.195

3 August 2017

0 references

cites work

CD5: a safeguard against autoimmunity and a shield for cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035976

Immunomodulation by mesenchymal stem cells and clinical experience

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035976

Rituximab for steroid-refractory chronic graft-versus-host disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035976

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035976

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035976

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035976

Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035976

Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035976

Human mesenchymal stem cells modulate allogeneic immune cell responses

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035976

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035976

Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035976

Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035976

CD8+CD28- T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035976

CD8(+)CD28(-) T suppressor cells represent a distinct subset in a heterogeneous population

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035976

Multilineage potential of adult human mesenchymal stem cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035976

Duration of immunosuppressive treatment for chronic graft-versus-host disease

7 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.195

Optimistic expectations and survival after hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.195

Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.195

Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.195

Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.195

Low-dose MTX for the treatment of acute and chronic graft-versus-host disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.195

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.195

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.195

Proteomic identification of differently expressed proteins responsible for osteoblast differentiation from human mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.195

Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.195

Chronic graft-versus-host disease: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.195

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.195

Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035976

Chronic graft-versus-host disease

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035976

The immunogenicity and immunomodulatory function of osteogenic cells differentiated from mesenchymal stem cells

27 October 2018

1 reference

12 December 2020

Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon

1 reference

12 December 2020

Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome

1 reference

12 December 2020

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients

1 reference

12 December 2020

Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage

1 reference

12 December 2020

Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

1 reference

12 December 2020

Repair of articular cartilage defects using mesenchymal stem cells

1 reference

12 December 2020

Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium

1 reference

12 December 2020

Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects

1 reference

12 December 2020

Using human adipose tissue-derived mesenchymal stem cells as salvage therapy for hepatic graft-versus-host disease resembling acute hepatitis

1 reference

12 December 2020

Human mesenchymal stem cells are tolerized by mice and improve skin and spinal cord injuries

1 reference

12 December 2020

Identifiers

DOI

10.1038/BMT.2010.195

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference